Zbog tehničkih razloga telefonska podrška danas neće biti dostupna, molimo kontaktirajte nas putem e-maila.

Provjerite status narudžbe

Pridružite se zajednici ljubitelja knjige iz cijelog svijeta i ostvarite mnoštvo pogodnosti. Izradite besplatni račun

Besplatna dostava Overseas kurirskom službom iznad 69.99 €

DPD kurir 3.99 € DPD točka 3.49 € GLS Kurir 4.99 € GLS paketomat 3.99 € Hrvatska pošta 4.99 € Dostava Overseas 4.99 € Box Now 4.49 €

Kontakt

Kako kupovati

Pomoć

Moj račun

▸ Prazno :-(

Zbog tehničkih razloga telefonska podrška danas neće biti dostupna, molimo kontaktirajte nas putem e-maila.

Knjige na engleskom > Medicine & Nursing > Medicine: general issues > Medical equipment & techniques > Medical research > Immunoregulation in Inflammatory Bowel Diseases - Current Understanding and Innovation

Immunoregulation in Inflammatory Bowel Diseases - Current Understanding and Innovation

Name: Immunoregulation in Inflammatory Bowel Diseases - Current Understanding and Innovation
Brand: Springer-Verlag New York Inc.
SKU: 01417174
Price: 204.43 EUR
Availability: InStock
Author: Axel Dignass
ISBN: 9781402058882

Current Understanding and Innovation

Axel Dignass

D. Rachmilewitz

Eduard F. Stange

Jezik

Engleski

Knjiga Tvrdi uvez

Libristo kod: 01417174

Nakladnici Springer-Verlag New York Inc., veljača 2007

Significant scientific progress has been made in recent years in the aetiopathogenesis of chronic in... Cijeli opis

Libristo kod: 01417174

498 b

204.43 €

Vanjske zalihe Šaljemo za 10-13 dana

Do 30 dana za povrat

Kupci su kupili i

Systematisch-Chronologische Darstellung der musikalischen Literatur Carl Ferdinand Becker

Meki uvez

25.82 €

Footloose in NYC Bill Bruford's Earthworks Audio

Audio CD

17.08 €

Vom Streben nach mehr Fabienne P.

Adobe ePub DRM

8.33 €

China im 21. Jahrhundert: Auf dem Weg zur Weltmacht Nr. 1? Ulrich Schnakenberg

Meki uvez

14.16 €

La nano-dentisterie Ashwini Tumkur Shivakumar

Meki uvez

49.54 €

Ocena składników odżywczych czosnku poddanego promieniowaniu gamma w celu poprawy jego eksportu Javeria Mirza

Meki uvez

38.99 €

Quelqu'un marchait derriere moi Clement Perrier

Adobe ePub DRM

7.03 €

Para curar a angustia causada pelos outros VÍCTOR MANUEL FERNÁNDEZ

Meki uvez

32.36 €

Die Kinder der Résistance Vincent Dugomier

Tvrdi uvez

14.36 €

Anouk, die nachts auf Reisen geht (Anouk 1) Peter Maffay

Tvrdi uvez

15.47 €

François de Dainville, S.J. (1909-1971) - pionnier de l'histoire de la cartographie et de l'éducation Knjiga

Meki uvez

37.98 €

Philosophiai Propadeutika, Part 1: A Lelektan Elemei (1882) Imre Pauer

Meki uvez

22.00 €

Handbuch für Reisende Karl Baedeker

Meki uvez

29.14 €

Anfänge Der Gross-Industrie in Oesterreich Hermann Hallwich

Meki uvez

16.37 €

Konzept des Cash Value Added Raman Malhotra

Meki uvez

22.30 €

Voyage d'Une Ignorante Dans Le MIDI de la France Et l'Italie. 2 (Ed.1835) Valerie Boissier De Gasparin

Meki uvez

26.53 €

Significant scientific progress has been made in recent years in the aetiopathogenesis of chronic inflammatory bowel diseases (IBD), that has changed or will change in the future the diagnostic and therapeutic approach in these diseases. The relevance of classical conventional IBD therapies has been critically re-evaluated under criteria of evidence-based medicine approaches. On the other hand, new therapeutic options have emerged. These include modern immunomodulators, biologics, probiotics, worm eggs and extracorporeal therapies. The clinical relevance of these new modalities is often difficult to assess for physicians who do not work frequently with IBD patients.§This book, the proceedings of the Falk Symposium No.153 on Immunoregulation in Inflammatory Bowel Diseases Current Understanding and Innovation , held May 6 7, 2006 in Berlin, Germany, critically discusses established and emerging new concepts in the diagnosis and treatment of IBD, reflecting the recent advancements in the aetiopathogenesis of these diseases. Controversial problems, such as the optimal therapeutic strategy (step-up versus top-down), therapy-associated side-effects and optimal control and selection of IBD therapies, are addressed by an internationally-renowned team of authors. The book will be essential reading for both basic scientists and clinicians.